As clinical data becomes more vulnerable to cyberattacks while gaining importance in the advancement of healthcare, hospitals must implement data security strategies.
The U.S. Food and Drug Administration is warning patients and health care providers that certain Medtronic MiniMed insulin pumps are being recalled due to potential cybersecurity risks and recommends that patients using these models switch their insulin pump to models that are better equipped to protect against these potential risks.
The FDA has launched a new pilot project to inform the development of a new electronic, interoperable track-and-trace system, anticipated for 2023, as part of the Drug Supply Chain Security Act (DSCSA).
Plans to make anthrax-antidote kits available to the 114 million households in the U.S. may lead to misuse of medicines and stir up public fears, advisers said.
